{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:58:00Z","timestamp":1785448680802,"version":"3.56.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The life expectancy of adult people with hemophilia has significantly increased thanks to therapeutic advancements, especially after the bloodborne infectious risks were controlled. However, no French data has yet documented this improvement. This study aims to compare the life expectancy of French people with hemophilia to that of the general population. A longitudinal study was conducted on 9,928 people with hemophilia included in the FranceCoag database between 1994 and 2022. Life expectancies were calculated using abridged life tables The life expectancies for people with hemophilia were 66.3 years at age 20 (mild hemophilia\u2009=\u200968.8, moderate\u2009=\u200964.8, severe\u2009=\u200960.4) and 47.5 years at age 40 (mild\u2009=\u200949.2, moderate\u2009=\u200945.9, severe\u2009=\u200942.7). Individuals with mild or moderate hemophilia had higher life expectancies compared to general population (59.8 years at age 20 and 40.7 years at age 40,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Those with severe hemophilia had a similar or slightly higher life expectancy at age 40. The mean differences in LE at ages 20 and 40, compared with the general population, varied markedly by severity, ranging from 0 to 10 years. Taken together, these findings suggest broadly comparable life expectancy in people with hemophilia, although differences remain according to disease severity. This improvement may be attributable both to recent therapeutic innovations and to more frequent and comprehensive medical follow-ups compared to the general population.\n                  <\/jats:p>","DOI":"10.1007\/s10654-026-01389-z","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:57:42Z","timestamp":1776844662000},"page":"743-753","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Life expectancy of people with hemophilia in France in 2022"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1420-0647","authenticated-orcid":false,"given":"Cl\u00e9mence","family":"Tab\u00e9l\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Boucekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Chambost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Tiade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doroth\u00e9e","family":"Pradines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Colle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Dalibard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djamel","family":"Kherfellah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Voltzenlogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Any","family":"Beltran Anzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc Anh Thu","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Resseguier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseline","family":"D\u2019Oiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Auquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"FranceCoag Study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"Suppl 6","key":"1389_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hae.14046","volume":"26","author":"A Srivastava","year":"2020","unstructured":"Srivastava A, Santagostino E, Dougall A, et al. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia. 2020;26(Suppl 6):1\u2013158.","journal-title":"Haemophilia"},{"issue":"8","key":"1389_CR2","doi-asserted-by":"publisher","first-page":"540","DOI":"10.7326\/M19-1208","volume":"171","author":"A Iorio","year":"2019","unstructured":"Iorio A, Stonebraker JS, Chambost H, et al. Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries. Ann Intern Med. 2019;171(8):540\u20136.","journal-title":"Ann Intern Med"},{"key":"1389_CR3","unstructured":"FranceCoag. Rapport annuel FC 2022 - Version tous publics - VF.pdf. https:\/\/www.francecoag.org\/presentation-de-france-coag\/bilan-activite-public\/. Accessed 11 Mar 2025."},{"issue":"9824","key":"1389_CR4","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/S0140-6736(11)61139-2","volume":"379","author":"E Berntorp","year":"2012","unstructured":"Berntorp E, Shapiro AD. Modern haemophilia care. Lancet. 2012;379(9824):1447\u201356.","journal-title":"Lancet"},{"key":"1389_CR5","unstructured":"RKAIN Maria. L\u2019h\u00e9mophilie au Maroc. \u00e9tat actuel et perspectives. centre de traitement de l\u2019h\u00e9mophilie. service d\u2019h\u00e9mato-oncologie p\u00e9diatrique du CHU RABAT-SALE (1981\u20132006). http:\/\/biblio.medramo.ac.ma\/opac_fmp\/index.php?lvl=author_see&id=10048. Accessed 11 Mar 2025."},{"issue":"1","key":"1389_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12288-012-0209-0","volume":"30","author":"HE Castro","year":"2014","unstructured":"Castro HE, Brice\u00f1o MF, Casas CP, Rueda JD. The history and evolution of the clinical effectiveness of haemophilia type A treatment: a systematic review. Indian J Hematol Blood Transfus. 2014;30(1):1\u201311.","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"5","key":"1389_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.7861\/clinmedicine.9-5-453","volume":"9","author":"CA Lee","year":"2009","unstructured":"Lee CA. The best of times, the worst of times: a story of haemophilia. Clin Med. 2009;9(5):453\u20138.","journal-title":"Clin Med"},{"key":"1389_CR8","unstructured":"Beny K. Parcours de sant\u00e9 du patient h\u00e9mophile et \u00e9valuation de l\u2019impact organisationnel d\u2019une innovation. https:\/\/theses.hal.science\/tel-04189399. Accessed 11 Mar 2025."},{"issue":"4","key":"1389_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.35772\/ghm.2023.01013","volume":"5","author":"AK Ghosh","year":"2023","unstructured":"Ghosh AK. Four decades of continuing innovations in the development of antiretroviral therapy for HIV\/AIDS: Progress to date and future challenges. GHM. 2023;5(4):194\u20138.","journal-title":"GHM"},{"issue":"6544","key":"1389_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/377079a0","volume":"377","author":"SC Darby","year":"1995","unstructured":"Darby SC, Ewart DW, Giangrande PLF, Dolin PJ, Spooner RJD, Rizza CR. Mortality before and after HIV infection in the complete UK population of haemophiliacs. Nature. 1995;377(6544):79\u201382.","journal-title":"Nature"},{"issue":"3","key":"1389_CR11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/jth.15182","volume":"19","author":"S Hassan","year":"2021","unstructured":"Hassan S, Monahan RC, Mauser-Bunschoten EP, et al. Mortality, LE, and causes of death of persons with hemophilia in the Netherlands 2001\u20132018. J Thromb Haemost. 2021;19(3):645\u201353.","journal-title":"J Thromb Haemost"},{"key":"1389_CR12","unstructured":"AERAS. La grille de r\u00e9f\u00e9rence AERAS. https:\/\/www.aeras-infos.fr\/sites\/aeras\/accueil\/la-convention-aeras\/le-cadre-de-la-convention-aeras\/le-droit-a-loubli-et-la-grille-1\/la-grille-de-reference-aeras-1.html. Accessed 11 Mar 2025."},{"issue":"5","key":"1389_CR13","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/S2352-3018(23)00028-0","volume":"10","author":"A Trickey","year":"2023","unstructured":"Trickey A, Sabin CA, Burkholder G, et al. LE after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. Lancet HIV. 2023;10(5):e295\u2013307.","journal-title":"Lancet HIV"},{"issue":"8","key":"1389_CR14","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","volume":"4","author":"A Trickey","year":"2017","unstructured":"Trickey A, May MT, Vehreschild JJ, et al. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4(8):e349\u201356.","journal-title":"Lancet HIV"},{"key":"1389_CR15","unstructured":"INSEE. Esp\u00e9rance de vie \u00e0 divers \u00e2ges. https:\/\/www.insee.fr\/fr\/statistiques\/2416631. Accessed 11 Mar 2025."},{"key":"1389_CR16","unstructured":"R\u00e9publique fran\u00e7aise. D\u00e9cision du 29 septembre 2021 relative aux conditions d\u2019octroi de cr\u00e9dits immobiliers. Code mon\u00e9taire et financier. Section 16, JORF n\u00b00237 du 10 octobre 2021. https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000044178669. Accessed 11 Mar 2025."},{"key":"1389_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-4384-7","volume-title":"The bootstrap and edgeworth expansion","author":"P Hall","year":"1992","unstructured":"Hall P. The bootstrap and edgeworth expansion. 1st ed. New York: Springer; 1992. https:\/\/doi.org\/10.1007\/978-1-4612-4384-7.","edition":"1"},{"key":"1389_CR18","doi-asserted-by":"publisher","DOI":"10.1201\/9781003401339","volume-title":"Modern statistics with R","author":"M Thulin","year":"2024","unstructured":"Thulin M. Modern statistics with R. 2nd ed. Boca Raton: Chapman & Hall\/CRC Press; 2024.","edition":"2"},{"key":"1389_CR19","unstructured":"CHR 2021 \u2013 AHCDC. Data summaries. https:\/\/ahcdc.ca\/chr-2021. Accessed 11 Mar 2025."},{"issue":"7","key":"1389_CR20","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1046\/j.1537-2995.1995.35795357875.x","volume":"35","author":"I Walker","year":"1995","unstructured":"Walker I, Pai M, Akabutu J, et al. The Canadian Hemophilia Registry as the basis for a national system for monitoring the use of factor concentrates. Transfusion. 1995;35(7):548\u201351.","journal-title":"Transfusion"},{"issue":"4","key":"1389_CR21","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1111\/hae.12477","volume":"20","author":"AN Traore","year":"2014","unstructured":"Traore AN, Chan AK, Webert KE, et al. First analysis of 10-year trends in national factor concentrates usage in haemophilia: data from CHARMS, the Canadian Hemophilia Assessment and Resource Management System. Haemophilia. 2014;20(4):e251\u20139.","journal-title":"Haemophilia"},{"key":"1389_CR22","unstructured":"Vankar P. Health and health systems ranking of countries worldwide in 2023. Health, Pharma & Medtech\u203a, State of Health https:\/\/www.statista.com\/statistics\/1376359\/health-and-health-system-ranking-of-countries-worldwide\/. Accessed 11 Mar 2025."},{"key":"1389_CR23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12879-015-0969-x","volume":"15","author":"S Patterson","year":"2015","unstructured":"Patterson S, Cescon A, Samji H, et al. LE of HIV-positive individuals on combination antiretroviral therapy in Canada. BMC Infect Dis. 2015;15:274.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"1389_CR24","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1093\/ije\/dys164","volume":"41","author":"MT May","year":"2012","unstructured":"May MT, Hogg RS, Justice AC, et al. Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics. Int J Epidemiol. 2012;41(6):1807\u201320.","journal-title":"Int J Epidemiol"},{"key":"1389_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2023.07.008","author":"JS Ostrenga","year":"2023","unstructured":"Ostrenga JS, Whitney Brown A, Todd JV, et al. Impact of loss to follow-up on survival estimation for cystic fibrosis. Ann Epidemiol. 2023. https:\/\/doi.org\/10.1016\/j.annepidem.2023.07.008.","journal-title":"Ann Epidemiol"},{"issue":"Suppl 1","key":"1389_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1365-3156.2010.02507.x","volume":"15","author":"EH Geng","year":"2010","unstructured":"Geng EH, Glidden DV, Emenyonu N, et al. Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa. Trop Med Int Health. 2010;15(Suppl 1):63\u20139.","journal-title":"Trop Med Int Health"},{"issue":"4","key":"1389_CR27","doi-asserted-by":"publisher","first-page":"00135","DOI":"10.1183\/23120541.00135-2023","volume":"9","author":"H Choi","year":"2023","unstructured":"Choi H, Mok J, Ae Kang Y, et al. Retreatment after loss to follow-up reduces mortality in patients with multidrug\/rifampicin-resistant tuberculosis. ERJ Open Res. 2023;9(4):00135\u20132023.","journal-title":"ERJ Open Res"},{"key":"1389_CR28","volume-title":"The life table and its applications","author":"CL Chiang","year":"1984","unstructured":"Chiang CL. The life table and its applications. 1st ed. Malabar: Robert E. Krieger Publishing Company; 1984.","edition":"1"},{"issue":"9635","key":"1389_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","volume":"372","author":"Antiretroviral Therapy Cohort Collaboration","year":"2008","unstructured":"Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293\u20139.","journal-title":"Lancet"},{"issue":"4","key":"1389_CR30","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1365-2141.1985.tb07353.x","volume":"59","author":"SA Larsson","year":"1985","unstructured":"Larsson SA. LE of Swedish haemophiliacs, 1831\u20131980. Br J Haematol. 1985;59(4):593\u2013602.","journal-title":"Br J Haematol"},{"issue":"3","key":"1389_CR31","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1182\/blood-2006-10-050435","volume":"110","author":"SC Darby","year":"2007","unstructured":"Darby SC, Kan SW, Spooner RJ, Giangrande PLF, Hill FGH, Hay CRM, et al. Mortality rates, LE, and causes of death in PWH A or B in the United Kingdom who were not infected with HIV. Blood. 2007;110(3):815\u201325.","journal-title":"Blood"},{"issue":"3","key":"1389_CR32","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1538-7836.2006.01808.x","volume":"4","author":"I Plug","year":"2006","unstructured":"Plug I, Van Der Bom JG, Peters M, et al. Mortality and causes of death in patients with hemophilia, 1992\u20132001: a prospective cohort study. J Thromb Haemost. 2006;4(3):510\u20136.","journal-title":"J Thromb Haemost"},{"key":"1389_CR33","unstructured":"\u00c9tat de sant\u00e9. de la population\u2009\u2013\u2009France, portrait social | Insee. https:\/\/www.insee.fr\/fr\/statistiques\/7666863?sommaire=7666953. Accessed 11 Mar 2025."},{"key":"1389_CR34","doi-asserted-by":"publisher","DOI":"10.4000\/sdt.1329","author":"R Crespin","year":"2017","unstructured":"Crespin R. Dominique Lhuilier et Anne-Marie Waser (dir.), Que font les 10 millions de malades? Vivre et travailler avec une maladie chronique. Sociologie du travail. 2017. https:\/\/doi.org\/10.4000\/sdt.1329.","journal-title":"Sociologie du travail"},{"issue":"9381","key":"1389_CR35","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0140-6736(03)14021-4","volume":"362","author":"A \u0160r\u00e1mek","year":"2003","unstructured":"\u0160r\u00e1mek A, Kriek M, Rosendaal FR. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet. 2003;362(9381):351\u20134.","journal-title":"Lancet"},{"issue":"5","key":"1389_CR36","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.jtha.2024.01.017","volume":"22","author":"C Dix","year":"2024","unstructured":"Dix C, Dolan G, Hunt BJ. Reducing the risk of atherosclerotic cardiovascular disease in PWH: the importance of primary prevention. J Thromb Haemost. 2024;22(5):1304\u201312.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"1389_CR37","first-page":"1","volume":"7","author":"AD Shapiro","year":"2022","unstructured":"Shapiro AD, Hardesty BM, Peyvandi F, Iorio A. Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: a scoping review. Res Pract Thromb Haemost. 2022;7(1):1\u201316.","journal-title":"Res Pract Thromb Haemost"},{"issue":"3","key":"1389_CR38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/rth2.12314","volume":"4","author":"F Kloosterman","year":"2020","unstructured":"Kloosterman F, Zwagemaker A, Abdi A, Gouw S, Castaman G, Fijnvandraat K. Hemophilia management: huge impact of a tiny difference. Res Pract Thromb Haemost. 2020;4(3):377\u201385.","journal-title":"Res Pract Thromb Haemost"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-026-01389-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10654-026-01389-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-026-01389-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:03:15Z","timestamp":1785445395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10654-026-01389-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1389"],"URL":"https:\/\/doi.org\/10.1007\/s10654-026-01389-z","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}